Evidence map›Paper›PMID 30811424›Full record

ArticlePloS one2019

Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation.

Dmitry A Ivlev, Shakhla N Shirinli, Konstantin G Guria, Svetlana G Uzlova, Georgy Th Guria

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dmitry A IvlevNational Research Center for Hematology, Moscow, Russia.
Shakhla N ShirinliMoscow Institute of Physics and Technology, Dolgoprudny, Russia.
Konstantin G GuriaMoscow Institute of Physics and Technology, Dolgoprudny, Russia.
Svetlana G UzlovaNational Research Center for Hematology, Moscow, Russia.
Georgy Th GuriaNational Research Center for Hematology, Moscow, Russia.ORCID 0000-0002-5579-9820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we investigated the capabilities of a novel ultrasonic approach for real-time control of fibrinolysis under flow conditions. Ultrasonic monitoring was performed in a specially designed experimental in vitro system. Fibrinolytic agents were automatically injected at ultrasonically determined stages of the blood clotting. The following clots dissolution in the system was investigated by means of ultrasonic monitoring. It was shown, that clots resistance to fibrinolysis significantly increases during the first 5 minutes since the formation of primary micro-clots. The efficiency of clot lysis strongly depends on the concentration of the fibrinolytic agent as well as the delay of its injection moment. The ultrasonic method was able to detect the coagulation at early stages, when timely pharmacological intervention can still prevent the formation of macroscopic clots in the experimental system. This result serves as evidence that ultrasonic methods may provide new opportunities for real-time monitoring and the early pharmacological correction of thrombotic complications in clinical practice.

Indexed as

Blood CoagulationFibrinolysisFibrinolytic AgentsHumansPlasminogenThrombolytic TherapyThrombosisTissue Plasminogen ActivatorUltrasonicsFibrinolytic AgentsPlasminogenTissue Plasminogen Activator

Identifiers

PMID30811424
PMCPMC6392241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.